🔎 Trials Near Me

Gara Jalqabaatti › Myelofibrosis › North Carolina › Durham

Qorannoo klinikaalii Myelofibrosis Durham, NC keessatti

Qorannoo 12 Myelofibrosis f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Namoota walitti qabaa jiraSadarkaa 1/2
  • Duke Cancer Institute, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Namoota walitti qabaa jiraSadarkaa 3
  • Duke Blood Cancer Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07623161

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • University of North Carolina At Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
  • University of North Carolina At Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

Registry of Older Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Namoota walitti qabaa jiraSadarkaa 1
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 13 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT04771572

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Namoota walitti qabaa jiraSadarkaa 3
  • DUHS Duke Blood Cancer Center ( Site 6005), Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06351631

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 2
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 hanga 66 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06859424

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Gur-2026 · NCT05980806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 27-Onk-2025 · NCT01137643

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Namoota walitti qabaa jiraSadarkaa 3
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT06479135

Qorannoo Myelofibrosis magaalota biroo keessatti

Qorannoo biroo Durham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.